Associated Papers
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance.
Cortés-López M et al.
Nature Communications, 2022
36138008 (PubMed )
Supplement: 41467_2022_31818_MOESM7_ESM.xlsx › All_annotated_variants
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy.
Zhang Z et al.
Journal for Immunotherapy of Cancer, 2020
Select a paper to view details